ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991